1. Holland EJ, Loh J, Bloomenstein M, Thompson V, Wirta D, Dhamdhere K. A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease. Clin Ophthalmol. 2022;16:2861-2871.Published 2022 Aug 30. doi:10.2147/OPTH.S368319
* $500 value to be utilized with the Dry Eye Institute or the Dry Eye University
† Professional evaluation of your Practice’s social media
Indications for Use: The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
The TearCare® System may not be right for everyone. Please see Instructions for Use or visit TearCare.com for Contraindications, Warnings, Precautions and Adverse Events.
The TEARCARE Clearance Assistant™ is indicated to express meibum from Meibomian glands. Refer to IFU for full contraindications, cautions, and potential adverse event information.
© 2023 Sight Sciences, Inc. 3/23 TC-2275-US.v3 TearCare, the TearCare logo, Sight Sciences, the Sight Sciences logo, SmartLids, Clearance Assistant, SmartHub are trademarks
or registered trademarks of Sight Sciences.